BG95967U - Лекарствена форма на база 4-хинолонови производни - Google Patents
Лекарствена форма на база 4-хинолонови производниInfo
- Publication number
- BG95967U BG95967U BG095967U BG9596792U BG95967U BG 95967 U BG95967 U BG 95967U BG 095967 U BG095967 U BG 095967U BG 9596792 U BG9596792 U BG 9596792U BG 95967 U BG95967 U BG 95967U
- Authority
- BG
- Bulgaria
- Prior art keywords
- dihydrate
- form based
- dihydro
- oxo
- fluoro
- Prior art date
Links
- HETSDWRDICBRSQ-UHFFFAOYSA-N 3h-quinolin-4-one Chemical class C1=CC=C2C(=O)CC=NC2=C1 HETSDWRDICBRSQ-UHFFFAOYSA-N 0.000 title abstract 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 4
- LEULAXMUNMRLPW-UHFFFAOYSA-N 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid;dihydrate Chemical compound O.O.CS(O)(=O)=O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 LEULAXMUNMRLPW-UHFFFAOYSA-N 0.000 abstract 2
- 229960003405 ciprofloxacin Drugs 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 229920002261 Corn starch Polymers 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 235000012222 talc Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Лекарствената форма на база 4-хинолонови производни, по-специално 1-циклопропил-6-флуоро-1,4-дихидро-4-оксо-7-1-/-1-пиперазини л/-хинолин-3-карбоксилова киселина-монохидрохлорид, монохидрат /ципрофлоксацин/ и 1-етил-6-флуоро-7/4-метил-1-пиперазинил/-4-оксо-1,4-дихидрох инолин-3-карбоксилова киселина метансулфонат дихидрат /пефлоксацинмезилат дихидрат/ намира приложение като антибактериално средство в хуманната медицина. Лекарствената форма съдържа ципрофлоксацин или пефлоксацин мезилат дихидрат, царевично нишесте, магнезиев стеарат, талк и нискомолекулярна карбоксиметилцелулоза натриева сол с м.т. 90000, степен на заместване 0,65 до 0,9 и съдържание на натрий от 0,7 до 8,9, вискозитет от 25 до 50 мраs на 2%-ен разтвор при 250с в концентрация от 0,3 до 2,0% тегловни. 1 претенция
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG95967U BG10Y1 (bg) | 1992-02-25 | 1992-02-25 | Лекарствена форма на база 4-хинолонови производни |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG95967U BG10Y1 (bg) | 1992-02-25 | 1992-02-25 | Лекарствена форма на база 4-хинолонови производни |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG95967U true BG95967U (bg) | 1995-02-28 |
| BG10Y1 BG10Y1 (bg) | 1996-02-29 |
Family
ID=3924288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG95967U BG10Y1 (bg) | 1992-02-25 | 1992-02-25 | Лекарствена форма на база 4-хинолонови производни |
Country Status (1)
| Country | Link |
|---|---|
| BG (1) | BG10Y1 (bg) |
-
1992
- 1992-02-25 BG BG95967U patent/BG10Y1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG10Y1 (bg) | 1996-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE309194T1 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| KR970706830A (ko) | 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2＇-dithio-bis (ethanesulfonate) (dimesna) | |
| NZ504017A (en) | Preparation of gatifloxacin and disodium edetate | |
| TR200000223T2 (tr) | XA faktörünü engelleyen heterosiklik türevler | |
| KR890011823A (ko) | 벤조일 페닐아세트산 유도체 약제 조성물 | |
| TR199901006T2 (xx) | Heterosiklik t�revler. | |
| ATE182593T1 (de) | Chemische verbindungen mit pde-iv inhibitierende wirkung | |
| BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
| EA199800775A1 (ru) | Таблетки, содержащие бетта-лактамный антибиотик, и способ их изготовления | |
| DK275488A (da) | Indolonderivater | |
| DE69731610D1 (de) | Orale verabreichung wirksamer mengen von hyaluronsäure | |
| TR200001542T2 (tr) | Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri. | |
| KR900015722A (ko) | N-(3,4-디메톡시신나모일) 안트라닐산을 함유하는 약제 조성물 | |
| BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
| KR920007629A (ko) | SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물 | |
| Nunn et al. | Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia: reversal with folinic acid | |
| DE69224071D1 (de) | Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen | |
| DK0866791T3 (da) | Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler | |
| TR200101163T2 (tr) | Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları | |
| NO20010454D0 (no) | Anvendelse av derivater av camptotécin med en redusert gastrointestinal toksisitet | |
| BG95967U (bg) | Лекарствена форма на база 4-хинолонови производни | |
| BR0116263A (pt) | Derivados de diidroindol e tetraidroquinolina | |
| BR0013723A (pt) | Uso de bissulfonamidas, para produção de medicamentos para profilaxia ou tratamento de hiperlipidemia | |
| Nightingale | Pharmacokinetic considerations in quinolone therapy | |
| HUP9904030A2 (hu) | Tiagabin felhasználása pszichotikus rendellenességek kezelésére alkalmas gyógyszer előállítására |